Platelet-rich plasma combined with skin substitute for chronic wound healing: A case report

Journal of Extra-Corporeal Technology

Volumn 38, Issue 3, 2006, Pages 260-264

  Knox, Rebecca L ^a,b   Hunt, Allen R ^a   Collins, John C ^a   DeSmet, Marie ^a   Barnes, Sara ^a  

^a Iowa Health System   (United States)

^b Trinity Medical Center   (United States)

Author keywords

Chronic wounds; Growth factors; Infection; Platelet rich plasma; Skin substitutes

Indexed keywords

GROWTH FACTOR;

ADULT; ARTICLE; BIOENGINEERING; BLOOD AUTOTRANSFUSION; CASE REPORT; CHRONIC DISEASE; DECUBITUS; DIAGNOSTIC VALUE; EPITHELIZATION; HUMAN; INDIVIDUALIZATION; MALE; SKIN SUBSTITUTE; THROMBOCYTE RICH PLASMA; TISSUE GRAFT; WOUND HEALING; ARTIFICIAL SKIN; BACK; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SKIN ULCER;

HUMANS; LUMBOSACRAL REGION; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; SKIN ULCER; SKIN, ARTIFICIAL; WOUND HEALING;

EID: 39049176898     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg. 1993;166:74-81.
2. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apheresis Sci. 2004;30:145-51.
3. Weed B, Davis MDP, Felty CL, et al. Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: A pilot study using a randomized, double-blind, placebo-controlled trial. WOUNDS. 2004;16:273-82.
4. Herouy Y, Mellios P, Bandemir E, et al. Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds. Int J Mol Med. 2000;6:515-9.
5. Glover JL, Weingarten MS, Buchbinder DS, Poucher RL, Deitrick GA III, Fylling CP. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care. 1997;10:33-8.
6. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001;24:483-8.
7. Trowbridge C, Stammers A, Woods E, et al. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol. 2005;37:381-6.
8. Lindemann S, Tolley N, Dixon D, et al. Activated platelets mediate inflammatory signaling by regulating interleukin 1B synthesis. J Cell Biol. 2001;3:485-90.
9. Dankert J, Krijgsveld J, van Der Werff J, Joldersma W, Zaat SA. Platelet microbicidal activity is and important defense factor against viridans streptococcal endocarditis. J Infect Dis. 2001;184:597-605.
10. Eisenbud D, Huang NF, Luke S, Silberklang M. Skin substitutes and wound healing: Current status and challenges. WOUNDS. 2004;16:2-17.
11. Brigido SA, Boc SF, Lopez RC. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: A pilot study. Orthopedics. 2004;27:s145-49.
12. Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg. 2004;62:489-96.